Assignee
GLYCOSTEM THERAPEUTICS B V
NL·1 granted patent·5 pending applications·0 citations·filing 2016–2021
Top patents by PatentIndex Score
6 records- 0151US2021228632A1Compostion for use in immunotherapyGLYCOSTEM THERAPEUTICS B V·Filed 2021·Application pending·0 cites
- 0249US2021054338A1Ex vivo nk cell differentiation from cd34+ hematopoietic cellsGLYCOSTEM THERAPEUTICS B V·Filed 2020·Application pending·0 cites
- 0342US2023212515A1Method for obtaining car-nk cellsGLYCOSTEM THERAPEUTICS B V·Filed 2020·Application pending·0 cites
- 0439US2022249567A1Low density cell cultureGLYCOSTEM THERAPEUTICS B V·Filed 2020·Application pending·0 cites
- 0534US2020016198A1Composition for use in immunotherapyGLYCOSTEM THERAPEUTICS B V·Filed 2016·Application pending·0 cites
- 0632US12304962B2CAR NK cellsGLYCOSTEM THERAPEUTICS B V·Filed 2019·Granted May 20, 2025·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when GLYCOSTEM THERAPEUTICS B V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →